Women with two risk alleles and low vitamin D status are nearly seven times more likely to have the sight-damaging disease, UB researcher and her team find.
National experts on behavioral neuroscience, adolescent substance abuse and prescription drug addiction will visit the UB Research Institute on Addictions during its Fall Seminar Series beginning Sept. 9.
How do the rigors of police work — from traumatic sights and sounds, to long work shifts and high demand levels — affect officers? A UB study seeks to answer that very important question.
UB has been awarded a prestigious, four-year, $15 million Clinical and Translational Science Award from the National Institutes of Health to speed the delivery of new drugs, diagnostics and medical devices to patients.
Medicare Part D provides help to beneficiaries struggling with the cost of prescriptions drugs, but the plan’s coverage gap hits some populations harder than others, particularly African-Americans age 65 and older.
Leaders from the University at Buffalo, Kaleida Health and Roswell Park Cancer Institute will brief the media about the importance to the community of the $15 million Clinical and Translational Science Award (CTSA) announced yesterday by the National Institutes of Health.
Kenneth Leonard, director of UB's Research Institute on Addictions, will be recognized for his outstanding scientific contributions with a national award from the American Psychological Association’s Society of Addiction Psychology.
The arrival last week of the 250-foot tower crane at Main and High streets in downtown Buffalo marks a new milestone in constructing the future home of the University at Buffalo’s School of Medicine and Biomedical Sciences.
Scientists from the University at Buffalo School of Dental Medicine will borrow a famous strategy from Greek warfare – the Trojan horse – to fight a fungus that exists in the mouths and skin of nearly half of the world’s population.